Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital Colorado
mi
from
Aurora, CO
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Emory University/Childrens Healthcare of Atlanta
mi
from
Atlanta, GA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Emory University/Childrens Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Riley Children's Hospital
mi
from
Indianapolis, IN
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Johns Hopkins University
mi
from
Baltimore, MD
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Harvard University, Boston Children's Hospital
mi
from
Boston, MA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Harvard University, Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of Michigan
mi
from
Ann Arbor, MI
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Columbia-Presbyterian
mi
from
New York, NY
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Columbia-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of Cincinnati, Cincinnati Children's Hospital
mi
from
Cincinnati, OH
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of Cincinnati, Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Medical Center of Dallas
mi
from
Dallas, TX
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Medical Center of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Baylor College of Medicine
mi
from
Houston, TX
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Univ of Washington
mi
from
Seattle, WA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of California at San Francisco
mi
from
San Francisco, CA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Mount Sinai Hosp
mi
from
New York, NY
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Hospital for Sick Children
mi
from
Toronto,
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Evaluating Vitamin D Content in Mushrooms
Evaluation of Vitamin D in a Mushroom Supplement
Status: Enrolling
Updated:  1/11/2016
Boston Med Ctr
mi
from
Boston, MA
Evaluating Vitamin D Content in Mushrooms
Evaluation of Vitamin D in a Mushroom Supplement
Status: Enrolling
Updated: 1/11/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Ultraviolet Light And Vitamin D In Subjects With Fat Malabsorption Or After Gastric Bypass Surgery
Ultraviolet Light and Vitamin D in Subjects With Fat Malabsorption or After Gastric Bypass Surgery
Status: Enrolling
Updated:  1/11/2016
Boston Med Ctr
mi
from
Boston, MA
Ultraviolet Light And Vitamin D In Subjects With Fat Malabsorption Or After Gastric Bypass Surgery
Ultraviolet Light and Vitamin D in Subjects With Fat Malabsorption or After Gastric Bypass Surgery
Status: Enrolling
Updated: 1/11/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer
Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer
Status: Enrolling
Updated:  1/11/2016
Mayo Clinic
mi
from
Jacksonville, FL
Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer
Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer
Status: Enrolling
Updated: 1/11/2016
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
Status: Enrolling
Updated:  1/12/2016
The Mayo Clinic
mi
from
Rochester, MN
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
Status: Enrolling
Updated: 1/12/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.
A Magnetic Resonance Imaging (MRI) Study to Investigate Differences in the Structure and the Function of the Brain at Rest; Between Persons With Functional Pain Conditions Such as IBS or Vulvodynia, IBD and Healthy Controls
Status: Enrolling
Updated:  1/12/2016
Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress
mi
from
Los Angeles, CA
Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.
A Magnetic Resonance Imaging (MRI) Study to Investigate Differences in the Structure and the Function of the Brain at Rest; Between Persons With Functional Pain Conditions Such as IBS or Vulvodynia, IBD and Healthy Controls
Status: Enrolling
Updated: 1/12/2016
Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  1/12/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 1/12/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
rHGH and Intestinal Permeability in Intestinal Failure
Influence of Recombinant Human Growth Hormone on Intestinal Permeability and Liver Injury in Intestinal Failure Patients Receiving Parenteral Nutrition (Serono Project)
Status: Enrolling
Updated:  1/12/2016
Northwestern Memorial Hospital
mi
from
Chicago, IL
rHGH and Intestinal Permeability in Intestinal Failure
Influence of Recombinant Human Growth Hormone on Intestinal Permeability and Liver Injury in Intestinal Failure Patients Receiving Parenteral Nutrition (Serono Project)
Status: Enrolling
Updated: 1/12/2016
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated:  1/13/2016
Stratton VA Medical Center
mi
from
Albany, NY
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated: 1/13/2016
Stratton VA Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated:  1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Clifton Park, NY
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated: 1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Clifton Park, NY
Click here to add this to my saved trials
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated:  1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Saratoga Springs, NY
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated: 1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Saratoga Springs, NY
Click here to add this to my saved trials
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated:  1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Troy, NY
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated: 1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Troy, NY
Click here to add this to my saved trials
Assessment of Endothelial Function, Apolipoproteins and Adiponectin
Assessment of Endothelial Function, Apolipoproteins, and Adiponectin Levels as Markers of Cardiovascular Before and After Liver Transplantation
Status: Enrolling
Updated:  1/13/2016
The Mayo Clinic
mi
from
Rochester, MN
Assessment of Endothelial Function, Apolipoproteins and Adiponectin
Assessment of Endothelial Function, Apolipoproteins, and Adiponectin Levels as Markers of Cardiovascular Before and After Liver Transplantation
Status: Enrolling
Updated: 1/13/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.
A Phase I Study Evaluating Safety and Tolerability of Autologous Bone Marrow Derived Mesenchymal Stromal (MSC) Cells in Adults With Moderate to Severe Crohn's Disease.
Status: Enrolling
Updated:  1/13/2016
Emory University
mi
from
Atlanta, GA
A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.
A Phase I Study Evaluating Safety and Tolerability of Autologous Bone Marrow Derived Mesenchymal Stromal (MSC) Cells in Adults With Moderate to Severe Crohn's Disease.
Status: Enrolling
Updated: 1/13/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Fresno, CA
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
La Jolla, CA
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Aurora, CO
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Gainesville, FL
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Atlanta, GA
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Atlanta, GA
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
New Orleans, LA
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Worcester, MA
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Detroit, MI
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
New York, NY
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Durham, NC
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Memphis, TN
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Fort Sam Houston, TX
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Houston, TX
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
San Antonio, TX
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated:  1/13/2016
Clinical Research Facility
mi
from
Richmond, VA
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).
Status: Enrolling
Updated: 1/13/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials